DaVita Inc. $DVA Shares Sold by Leonteq Securities AG

Leonteq Securities AG reduced its holdings in shares of DaVita Inc. (NYSE:DVA) by 87.8% in the 1st quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 346 shares of the company’s stock after selling 2,482 shares during the quarter. Leonteq Securities AG’s holdings in DaVita were worth $53,000 as of its most recent filing with the Securities and Exchange Commission.

Several other institutional investors and hedge funds also recently modified their holdings of DVA. Peregrine Asset Advisers Inc. purchased a new position in DaVita during the first quarter worth $231,000. Root Financial Partners LLC lifted its position in shares of DaVita by 128.0% in the first quarter. Root Financial Partners LLC now owns 187 shares of the company’s stock valued at $29,000 after acquiring an additional 105 shares in the last quarter. Apollon Wealth Management LLC acquired a new stake in shares of DaVita during the first quarter valued at $217,000. Pictet Asset Management Holding SA increased its position in DaVita by 9.1% during the 1st quarter. Pictet Asset Management Holding SA now owns 8,242 shares of the company’s stock worth $1,267,000 after purchasing an additional 684 shares in the last quarter. Finally, Louisiana State Employees Retirement System purchased a new stake in DaVita during the 1st quarter worth about $261,000. Hedge funds and other institutional investors own 90.12% of the company’s stock.

Insider Buying and Selling

In other DaVita news, CFO Joel Ackerman sold 51,471 shares of DaVita stock in a transaction that occurred on Thursday, May 7th. The shares were sold at an average price of $192.10, for a total transaction of $9,887,579.10. Following the transaction, the chief financial officer directly owned 132,434 shares of the company’s stock, valued at $25,440,571.40. The trade was a 27.99% decrease in their ownership of the stock. The sale was disclosed in a filing with the SEC, which is accessible through this hyperlink. Also, insider Kathleen Alyce Waters sold 15,405 shares of the stock in a transaction on Monday, June 15th. The stock was sold at an average price of $208.40, for a total transaction of $3,210,402.00. Following the completion of the sale, the insider directly owned 109,194 shares of the company’s stock, valued at $22,756,029.60. The trade was a 12.36% decrease in their position. The disclosure for this sale is available in the SEC filing. 1.50% of the stock is currently owned by corporate insiders.

Analysts Set New Price Targets

A number of research analysts have issued reports on DVA shares. TD Cowen upped their target price on shares of DaVita from $144.00 to $201.00 and gave the company a “hold” rating in a report on Monday, May 11th. Barclays set a $218.00 price objective on shares of DaVita in a research report on Wednesday. Zacks Research downgraded shares of DaVita from a “strong-buy” rating to a “hold” rating in a research note on Monday. UBS Group raised their target price on shares of DaVita from $190.00 to $235.00 and gave the stock a “buy” rating in a research report on Thursday, May 7th. Finally, Deutsche Bank Aktiengesellschaft upgraded DaVita from a “hold” rating to a “buy” rating and boosted their price target for the company from $126.00 to $220.00 in a report on Wednesday, May 6th. Two investment analysts have rated the stock with a Buy rating, five have issued a Hold rating and one has given a Sell rating to the company. According to MarketBeat, the stock presently has a consensus rating of “Hold” and a consensus target price of $203.17.

DaVita Trading Down 1.5%

Shares of DVA opened at $230.75 on Thursday. DaVita Inc. has a twelve month low of $101.00 and a twelve month high of $239.64. The firm has a market capitalization of $14.81 billion, a P/E ratio of 21.41, a price-to-earnings-growth ratio of 0.77 and a beta of 0.88. The stock’s fifty day simple moving average is $201.31 and its 200 day simple moving average is $159.01.

DaVita (NYSE:DVA) last posted its quarterly earnings results on Tuesday, May 5th. The company reported $2.87 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $2.33 by $0.54. The firm had revenue of $3.42 billion during the quarter, compared to the consensus estimate of $3.36 billion. DaVita had a negative return on equity of 270.37% and a net margin of 5.65%.The firm’s quarterly revenue was up 6.0% compared to the same quarter last year. During the same quarter in the previous year, the business earned $2.00 earnings per share. DaVita has set its FY 2026 guidance at 14.100-15.200 EPS. Sell-side analysts predict that DaVita Inc. will post 15.07 earnings per share for the current year.

About DaVita

DaVita Inc (NYSE: DVA) is a leading provider of kidney care services, specializing in the management and operation of outpatient dialysis centers for patients with chronic kidney failure and end-stage renal disease. Headquartered in Denver, Colorado, the company offers a comprehensive suite of treatment modalities, including in-center hemodialysis, peritoneal dialysis, and home dialysis therapies. In addition to its core dialysis services, DaVita provides patient education, nutritional counseling, vascular access management and related laboratory services to support kidney health and overall patient well-being.

Since its formation in the mid-1990s through a clinical management services spin-off, DaVita has expanded both organically and through strategic partnerships and acquisitions.